Connect with us

featured

Texas Lawmakers Passed Bills To Expand Medical Marijuana, Ban Hemp And Support Psychedelic Research This Session

Published

on


Lawmakers reasoned that removing hemp options from the general public could be offset by expanding the medical marijuana industry.

By Stephen Simpson, The Texas Tribune

Texas lawmakers this year heavily focused their drug policy agenda on banning tetrahydrocannabinol, or THC, products in the state.

Senate Bill 3, which prohibits the possession of consumable hemp products that contain any synthetic cannabinoid, often known as delta-8, was a priority for Lt. Gov. Dan Patrick (R), who often denounced the effects of the drug on children. As a concession of sorts to veterans and THC users with chronic conditions, House Bill 46 also passed, expanding the state’s medical marijuana program by providing more products to users and adding more qualifying conditions.

Both bills found themselves tied together as lawmakers reasoned that removing hemp options from the general public could be offset by expanding the medical marijuana industry.

While the focus was primarily on THC this session, Texas quietly passed Senate Bill 2308, which would create a state-funded consortium to research a psychedelic drug called ibogaine. The clinical trials would test whether ibogaine is a viable treatment for substance use disorders and other mental health conditions.

However, multiple bills that could have prevented overdose deaths failed to gain traction this year. House Bill 1644, for example, would have removed testing strips for fentanyl and xylazine, a veterinary sedative also known as “tranq,” from the list of banned drug paraphernalia.

The hemp debate

In 2019, Texas lawmakers embraced the potential to boost the state’s agricultural market by legalizing hemp products derived from cannabis plants with less than 0.3 percent of THC.

Six years later, SB 3 intends to shut down the $8 billion hemp industry and cut its estimated 50,000 jobs when the ban takes effect in September.

Critics say the hemp industry has exploited a loophole in the 2019 law to the tune of more than 8,000 retailers now selling THC-laced edibles, drinks, vapes and flower buds.

The proposed law would ban consumable hemp products that contain any synthetic cannabinoid, often known as delta-8. Non-intoxicating and non-psychoactive CBD or CBG would remain legal.

People found in possession of a product with those intoxicating cannabis compounds could face a fine of up to $500. Higher fines and jail time would be possible for repeat offenders.

Hemp industry leaders and advocates have denied any harmful intentions and are in favor of regulations on the industry rather than a ban.

Aging Texans, veterans, and parents of children with mental illness or special needs have spoken out about the benefits of hemp, including the ease of access, the variety of products available to them and the lower price. In contrast, concerned parents demanded a ban because they fear children would be harmed from recreational use.

The Texas Hemp Business Council reported that it delivered 5,000 letters to Abbott’s office earlier this week, along with a petition signed by over 120,000 people, urging the governor to veto the bill. Abbott has until June 22 to decide on a veto.

Expanding medical marijuana

In Texas, licensed medical cannabis providers must house all operations—including cannabis cultivation, processing, extracting, manufacturing, testing and dispensing—under one roof.

State regulations also prohibit inventory storage of medical cannabis products in multiple locations, so products must be distributed from the central dispensary. Any prescriptions scheduled for pickup outside the central dispensary must be driven daily to and from the pickup location—sometimes hundreds of miles round-trip.

This has made their products more expensive and limited where the medical marijuana program can reach, hampering the small medical cannabis market in Texas.

HB 46 aims to help by expanding the program to include more popular products such as prescribed inhalers and vaping devices, allow off-site storage and add nine dispensers, bringing the total to 12. It also adds traumatic brain injuries, chronic pain, Crohn’s disease and terminal illnesses to the list of qualifying conditions.

The first three dispensers will be selected from the previously submitted 2015 list of dispensers and then made available to the public.

The expansion of the medical marijuana program will go into effect in September if Abbott signs it into law.

Psychedelics research

Among drug-related bills that received less attention was SB 2308, which will make Texas a hub for ibogaine-related research, development, treatment, manufacturing and distribution. This will be accomplished by creating a consortium that includes higher education institutions, drug developers, nonprofits, and other stakeholders to secure U.S. Food and Drug Administration approval for a treatment.

Ibogaine is a psychedelic found in the roots of the iboga plant, primarily found in Africa, and has been used for centuries during shamanistic rituals due to its ability to induce hallucinations in large doses. The drug has been illegal in many countries, but scientists recently announced a study finding that, in low doses, ibogaine might have beneficial uses to treat addiction, PTSD and brain injuries.

The bill could essentially give Texas a stake in any future revenue that may come from the state developing a medical use for ibogaine.

The program will be funded through a $50 million appropriation from the state’s general fund.

Less emphasis on drug overdose policies

Fentanyl, a potent drug commonly mixed with other substances and has caused the deaths of more than 7,000 Texans in the last six years, is odorless and tasteless, making detection nearly impossible without specialized equipment.

Fentanyl test strips are among the cheapest and easiest ways to prevent overdoses, but for a third time, legislation to legalize them failed in the Senate.

HB 1644, which would have legalized opioid drug testing strips, never got a hearing in the Senate despite passing unanimously in the House.

The main argument against drug testing strips has been that it encourages continued drug use, but advocates deny this claim, saying that once someone is thinking about their safety, it is by the time they are getting close to quitting.

Senate Bill 1732, which would have allowed nurses and physician assistants to prescribe medication-assisted treatment, like methadone and buprenorphine, for opioid use disorders, also never received a committee hearing.

A smaller step lawmakers made to address overdoses comes in House Bill 4783, which requires the Texas Health and Human Services Commission to prepare a report every two years for lawmakers to evaluate the distribution of opioid overdose reversal drugs, like Narcan. The report will be required to create a statewide goal for opioid reversal drugs and include an estimate of insufficiencies in the current supply and a plan to address overdoses in high-risk areas.

This article originally appeared in The Texas Tribune at https://www.texastribune.org/2025/06/06/texas-hemp-marijuana-drugs-policy-legislature/.

The Texas Tribune is a member-supported, nonpartisan newsroom informing and engaging Texans on state politics and policy. Learn more at texastribune.org.

Key GOP Congressmen, Including Pro-Marijuana Legalization Member, Defend Effort to Ban Consumable Hemp Products

Photo courtesy of Chris Wallis // Side Pocket Images.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Become a patron at Patreon!





Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

featured

Federal Researchers Claim First-Ever Detection Of Cannabinoids In Human Breath After Use Of Marijuana Edibles

Published

on


Federal researchers at the National Institute of Standards and Technology (NIST) say they’ve made the first-ever detection of THC in human breath following the consumption of infused edibles—a possible step forward in terms of field testing for cannabis impairment.

But more research is necessary, they add, pointing to “uncertainty of breath measurements” and the need to further analyze the detectability of cannabinoids over longer time periods.

“This is an important step forward, that we can detect THC increases in breath after the ingestion of cannabis,” Jennifer Berry, a NIST research chemist and the lead author on the paper, said in an agency release about the new findings, which were published earlier this month in the Journal of Analytical Toxicology.

Three NIST researchers and one from University of Colorado Anschutz Medical teamed up on the project, which the report describes as a “proof-of-concept study.” It’s part of the federal agency’s broader research into cannabis use and driving performance.

Breath samples of 29 participants were collected before and after ingesting a THC-infused edible, which subjects were asked to bring in themselves. The products ranged in strength from five milligrams to 100 mg THC, though the report notes the amounts were not independently verified.

“NIST and its partners at University of Colorado Anschutz have made the first measurement of tetrahydrocannabinol (THC) in breath from edible cannabis.”

Collection was done using two different devices, one described as an aerosol device and the other as a condensate device. Samples were taken before ingestion and at three timepoints afterward: roughly 47 minutes, 92 minutes and 180 minutes.

Though participants were instructed to abstain from using edible cannabis for 12 hours prior to the study and from inhaling cannabis for 8 hours ahead of time, samples for nearly all participants detected THC even before they ingested the infused edibles.

“THC was detected in breath samples from 27 of the 29 participants before edible ingestion, ranging from trace (10 participants) to greater than 0.4 ng/device,” the report says, noting that similar phenomena around residual THC had been observed in prior studies.

“The finding of detectable and/or quantifiable THC before cannabis use,” authors wrote, “shows how challenging it is to interpret a single THC concentration measurement in breath with no prior information about THC at baseline.”

“The high detection rate of THC in breath after 8 h of requested abstinence,” they added later in the report, “shows that identifying recent use from a single measurement is challenging from any matrix.”

After ingesting the edibles, measured THC levels in the breath of most participants—but not all—rose over time.

“Of the 29 participants in this study, 19 showed a significant increase in THC concentration after edible ingestion (at any of the three post-use timepoints), 4 showed no change, and 6 showed a significant decrease in THC concentration after edible use,” the study says.

Those who showed a decrease in THC levels, it points out, also reported some of the highest THC levels prior to taking the edibles.

Those whose THC breath levels rose or remained stable, however, support the notion that breath-based tests can detect recent cannabis use, authors asserted.

“Breath samples from two-thirds of the participants in this study showed an increase in THC concentration after cannabis ingestion,” they wrote, “but the remaining one-third are not necessarily inconsistent with the hypothesis that recent cannabis use can be detected in breath, regardless of the mode of use.”

Notably, measured levels of THC and some other cannabinoids seem to change in similar ways. But THC and CBD levels didn’t always track with each other.

“When detected, CBN and CBG matched THC trends, but there were multiple instances where CBD and THC disagreed,” the study says, “suggesting differences in biological processing or clearance.”

In the NIST press release, Tara Lovestead, a chemical engineer on the breath research project, said the study “supports the idea that multiple breath measurements over a period of time could be a way to use a breathalyzer to detect cannabis use, regardless of how it’s ingested.”

“However,” the scientist added, “devices will still need standards to ensure that they are accurate and used correctly, standards that don’t yet exist.”

NIST notes in its press release that the agency itself is not developing a cannabis breath-testing device. “Instead, NIST’s role is to help ensure that measurements of cannabis in breath can be accurate, reliable and have scientifically sound standards behind them,” it says.

“Looking forward, we can now tackle the question of when THC increases after edible ingestion, when it goes back to baseline, and how to analyze breathalyzer data to get the information needed.” said Kavita Jeerage, a NIST research chemical engineer who the agency’s cannabis breath research.

The agency is set to host a workshop with device makers in September.

The event was originally scheduled to be held in Boulder, Colorado, in April, but a month ahead of the originally scheduled event, it was abruptly postponed.

According to a preliminary agenda sent to Marijuana Moment by NIST earlier this year, topics to be discussed will include challenges facing marijuana breathalyzer design and development, obstacles to prosecutors handling drugged-driving cases and how NIST and others might partner to advance the technology.

Findings of the workshop, “Building a Path Forward for Meaningful Cannabis Breathalyzer Realization,” are set to be compiled into a NIST internal report that the agency has said will be publicly available.

Unlike with alcohol, there’s currently no widely accepted field test to determine whether someone is under the influence of marijuana.

In 2023, a federally funded report by researchers at NIST and the University of Colorado Boulder concluded that evidence does “not support the idea that detecting THC in breath as a single measurement could reliably indicate recent cannabis use.”

“A lot more research is needed to show that a cannabis breathalyzer can produce useful results,” Jeerage at NIST said at the time. “A breathalyzer test can have a huge impact on a person’s life, so people should have confidence that the results are accurate.”

More recently, a U.S. Department of Justice researcher cast doubt on whether a person’s THC levels are even a reliable indicator of impairment.

States may need to “get away from that idea,” Frances Scott, a physical scientist at the National Institute of Justice (NIJ) Office of Investigative and Forensic Sciences under DOJ, said on a podcast early last year.

Scott questioned the efficacy of setting “per se” THC limits for driving that some states have enacted, making it so a person can be charged with driving while impaired based on the concentration of cannabis components in their system. Ultimately, there may not be a way to assess impairment from THC like we do for alcohol, she said.

One complication is that “if you have chronic users versus infrequent users, they have very different concentrations correlated to different effects,” Scott said. “So the same effect level, if you will, will be correlated with a very different concentration of THC in the blood of a chronic user versus an infrequent user.”

That issue was also examined in a federally funded study last year that identified two different methods of more accurately testing for recent THC use that accounts for the fact that metabolites of the cannabinoid can stay present in a person’s system for weeks or months after consumption.

The THC impairment question has nevertheless been a major focus for lawmakers and the research community, particularly as it concerns driving laws.

Last October, a study preprint posted on The Lancet by an eight-author team representing Canada’s Centre for Addiction and Mental Health, Health Canada and Thomas Jefferson University in Philadelphia identified and assessed a dozen peer-reviewed studies measuring “the strength of the linear relationship between driving outcomes and blood THC” published through September 2023.

“The consensus is that there is no linear relationship of blood THC to driving,” the paper concluded. “This is surprising given that blood THC is used to detect cannabis-impaired driving.”

Most states where cannabis is legal measure THC intoxication by whether or not someone’s blood THC levels are below a certain cutoff. The study’s findings suggest that relying on blood levels alone may not accurately reflect whether someone’s driving is impaired.

“Of the 12 papers included in the present review,” authors wrote, “ten found no correlation between blood THC and any measure of driving, including [standard deviation of lateral position (SDLP)], speed, car following, reaction time, or overall driving performance. The two papers that did find a significant association were from the same study and found significant relationship with blood THC and SDLP, speed and following distance.”

Earlier last year, researchers behind a federally funded study said they’d developed new procedures to enhance the selectivity of a popular forensic testing method, allowing better detection of delta-9 THC and its metabolites in blood.

A 2023 congressional report for a Transportation, Housing and Urban Development, and Related Agencies (THUD) bill said that the House Appropriations Committee “continues to support the development of an objective standard to measure marijuana impairment and a related field sobriety test to ensure highway safety.”

A year earlier Sen. John Hickenlooper (D) of Colorado sent a letter to the Department of Transportation (DOT) seeking an update on that status of a federal report into research barriers that are inhibiting the development of a standardized test for marijuana impairment on the roads. The department was required to complete the report under a large-scale infrastructure bill that President Joe Biden signed, but it missed its reporting deadline.

A study published in 2019 concluded that those who drive at the legal THC limit—which is typically between two to five nanograms of THC per milliliter of blood—were not statistically more likely to be involved in an accident compared to people who haven’t used marijuana.

Separately, the Congressional Research Service in 2019 determined that while “marijuana consumption can affect a person’s response times and motor performance … studies of the impact of marijuana consumption on a driver’s risk of being involved in a crash have produced conflicting results, with some studies finding little or no increased risk of a crash from marijuana usage.”

Another study from 2022 found that smoking CBD-rich marijuana had “no significant impact” on driving ability, despite the fact that all study participants exceeded the per se limit for THC in their blood.

Evan as far back as 2015, a U.S. National Highway Traffic Safety Administration (NHTSA) concluded that it’s “difficult to establish a relationship between a person’s THC blood or plasma concentration and performance impairing effects,” adding that “it is inadvisable to try and predict effects based on blood THC concentrations alone.”

In a separate report last year, NHTSA said there’s “relatively little research” backing the idea that THC concentration in the blood can be used to determine impairment, again calling into question laws in several states that set “per se” limits for cannabinoid metabolites.

“Several states have determined legal per se definitions of cannabis impairment, but relatively little research supports their relationship to crash risk,” that report said. “Unlike the research consensus that establishes a clear correlation between [blood alcohol content] and crash risk, drug concentration in blood does not correlate to driving impairment.”

Earlier this month, meanwhile, a Rutgers University law professor published commentary arguing that roadside tests for marijuana impairment used widely by police departments across the country are “inadequate” and “pseuduscientific,” urging policymakers to take a more evidence-based robust approach to transportation safety while relying less on law enforcement’s ostensible expertise.

The paper, by William J. McNichol of Rutgers University’s Camden School of Law, asserts that current approaches to detecting cannabis impairment “either merely imitate tools used to identify alcohol based impairment without taking into account important differences between the effects of these molecules or they are pseudoscientific ‘police science.’”

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Become a patron at Patreon!



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading

featured

BREEDING FOR BIG BUDS (1986)

Published

on


Original publication: November 1986.

BREEDING FOR BIG BUDS

HARVEST ’86

BY JORGE CERVANTES

“Look at the size of that thing, I must be hallucinating,” said Tim as he stared in awe at the huge six-inch diameter flower top. “What did you put in this joint to make me see things twice as big as life? I mean, that is the biggest bud I’ve ever seen!”

“We call her Big Bud. I think she is 100% Indica,” replied James with a big smile. “I brought her back to Detroit from out West. Here, give her a try,” said James, passing Tim a bomber of Big Bud.

Tim put the spliff between his lips and gently drew a few breaths through the unlit joint. “So fresh and minty, it’s the best I’ve ever tasted. I take back all the bad stuff I said about indoor smoke,” Tim said with a pleased sheepish grin.

“They’ve been breeding some incredible plants out on the West Coast. When I was there, indoor growers were talking about the Hash Plant that matures into a 36″ tall two-three ounce plant (dried tops only) after eight weeks of flowering: stout, broad tops laden with thick gooey resin. Or Lime Bud, a Sativa/lndica cross, with long, dainty, lime green leaves and lightweight buds packed with pistils and glistening resin glands. Or Northern Lights, a mainstay variety in Vancouver, B.C. that matures into a four-foot, four ounce plant at the ripe old age of 85 to 90 days. But everyone’s favorite is Big Bud because she grows huge buds and has the sweetest, mintiest taste in the world. My last crop weighed in at 3 1/2 pounds, that’s better than four ounces a plant!”

Narrow leaves show classic qualities.

All of these varieties were developed by industrious, careful and caring individuals that have kept meticulous detailed records of plant growth habits and the offspring that resulted when they crossed a male plant with a female. Indoor breeding is two or three times faster than outdoors. As many as three generations may easily be completed in one year indoors. The breeder controls the hours of light and darkness per day, causing the plants to flower and produce seed at will.

Selective breeding (also known as selective sexual propagation) has completely changed the quality and yield of indoor marijuana crops. The starting point is to collect marijuana seed from well known pot growing regions throughout the globe. The various seed strains are grown and studied thoroughly without any cross breeding. Once each is understood, then selective breeding can begin, either to attain a pure seed stock, or to improve the strain. Once the ultimate plant is developed through this sexual propagation, it can be cloned to preserve the genetic blueprint created by selective breeding.

Cannabis Indica seeds are highly prized for their potency and adaptability to the indoor environment. The characteristics of Indica plants include: squat, bushy, vigorous growth; early, sustained potency; disease resistance; and heavy bud yield. An Indica plant may yield two to four times the dry bud weight of a Sativa at harvest. Thai, Colombian, and Mexican are examples of Cannabis Sativa. These Sativa varieties are tall, lanky, and disease resistant, with narrow, long leaves and light buds that take up to three months to mature. But the high is energetic, soaring, and clear.

Ideally, skilled breeders will strive to retain the desirable dominant growth characteristics of both Cannabis Sativa and Cannabis Indica to form super strains. Breeders may cross a Sativa with an Indica, hoping to retain the desirable soaring high while keeping the short, stocky growth characteristics and early maturity of the Indica.

This single indica female bud is being fertilized by male pollen in the plastic baggie.

Selective breeding requires the breeder to simply assume the role of Mother Nature once again. In nature, pollen from the male cannabis plant is shed into the wind to randomly fertilize any receptive female plant. A breeder adds precision and control to this process by catching pollen from a desirable male and carefully placing it in contact with chosen female pistils.

Two basic kinds of breeding are: (1) inbred or true bred—plants of the same strain or ancestry that are crossed with one another. (2) outbred or hybrid— plants of different strains that are crossed or cross-pollinated.

The goal of inbreeding is to establish a pure breed to start from. Selected females are pollinated with male pollen of the same strain, then the resulting seeds are planted and checked for variability. This process may take several generations to produce a strain that actually breeds true. Pure bred plants are grown until the fifth to sixth generation, after which negative characteristics, like low potency, legginess and lack of vigor tend to dominate.

This true or pure breed is essential to establish common growth characteristics. Without a pure breed on one or both sides, it is difficult to predict the outcome of a hybrid cross. Ideally, both male and female are pure-bred plants, with known ancestry and growth attributes.

A hermaphroditic plant (a plant displaying both male and female flowers) will self-pollinate and produce inbred seeds. Although this is a shortcut to inbreeding, the seedlings resulting from self-pollination may tend to be hermaphroditic themselves. This can be a real headache for the sinsemilla grower or breeder, with unwanted seeds and uncontrolled pollen. Nonetheless, the seed produced by a hermaphrodite that has just a few male flowers on a female plant will be 80-90% female seed. One easy way to produce seeds from an all female clone crop is to stress one of the female branches by twisting a piece of wire around one of the branches a couple of weeks before flowering is induced. The extra stress will usually cause the plant to produce male flowers.

Outbreeding, or producing hybrid seed, has increased agricultural production more than anything. Farmers, breeders and cannabis horticulturists have found that crossing parents of different pure strains, especially those exhibiting exceptional, dominant, complementary characteristics, will result in a super plant, also referred to as hybrid vigor.

It is possible to cross Sativa/lndica. Some growers swear by the cross, saying you get the best of both plants: vigor and size from the Sativa, and squat, bushy, early, potent growth from the Indica.

Choosing from a large and varied plant stock is the key to successful breeding. Since the origin of most seed is dubious, an accomplished breeder waits to see what kind of plant it produces, before deciding which plants to cross to form hybrid seed. If the breeder plants only a few seeds, there is no guarantee that they will grow into ideal breeding stock, even if they came from dynamite smoke. If the breeder instead selects the best plants from many seedlings of various strains of Cannabis Indica (and/or Sativa), he or she will have a better chance of achieving the desired outcome.

BREEDING: STEP-BY-STEP

STEP ONE: Choose male breeding stock exhibiting desirable characteristics.

STEP TWO: One branch full of male flowers is all that will be needed, unless a large crop is desired. Unused branches may be stripped of flowers to help contain pollen and guard against accidental, random pollination. The male can be isolated from the females, once flowers have developed, but not yet opened, by placing him in a sunny window or in a vegetative grow room. This will slow flower development and not hurt the male in any way.

A branch of ripe, male flower may be cut and placed in water. It will remain healthy for several weeks. When the pollen sacks open, proceed with Step Three. The remaining male plant may then be cut back or harvested.

Skilled breeders will cross a Sativa with an Indica, hoping to retain the Sativa’s soaring high while keeping the stocky growth and early maturity of the Indica.

STEP THREE: When the pollen pods start to open, place a clean, plastic sack or baggie over the branch to collect pollen. Secure the bag at the bottom with a piece of string or wire tie. Keep the bag over the branch for several days to collect pollen.

STEP FOUR: When enough pollen has been collected, shake remaining pollen off into the bag. Remove spent branch. Pollen may be kept for several weeks by removing all vegetative matter to prevent mold, and storing the pollen in a dark, dry container in the refrigerator.

STEP FIVE: Ideally, pistils should be ready for fertilization three to four weeks after the first calyx has appeared. Receptive pistils are white and fuzzy, not starting to turn brown. Cover the selected female branch that has many ripe, receptive pistils with the pollen-filled bag. Shake the bag.

STEP SIX: Use a small paint brush to apply the pollen from the bag to the pistils if just a few seeds are desired from many different females. Be very careful. Just use a little pollen on each calyx and keep it from spreading to the sinsemilla crop.

STEP SEVEN: Leave the bag for two or three days, to ensure fertilization. Be careful not to scatter pollen on adjacent sinsemilla crop when removing the bag.

STEP EIGHT: After fertilization, seeds will be ripe in three-six weeks. Harvest seeds when they split open the containing calyx or rattle in the pod.

STEP NINE: Let seeds dry for two to three months, in a cool, dry place, before planting.

This is the eighth in a series of articles by Jorge Cervantes, author of the bestselling INDOOR MARIJUANA HORTICULTURE, known by many as the Bible of indoor growing. The series outlines indoor growing from A-Z, for both novices and experienced gardeners alike.



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading

featured

New DEA Admin Sidelines Cannabis Rescheduling Despite Earlier Promises

Published

on


Terrance C. Cole, the newly appointed Administrator of the Drug Enforcement Administration (DEA), failed to mention the stalled cannabis rescheduling process in a recent release outlining his eight top priorities for the federal agency.

During his confirmation hearings, when lawmakers asked about moving cannabis from Schedule I to Schedule III, Cole said that investigating the issue would be “one of my first priorities” if appointed to the position.

However, now that he has been confirmed, the new DEA chief has announced the agency’s first eight priorities, and none of them relate to the stalled cannabis rescheduling process. Instead, Cole says the agency will focus on enforcement actions like targeting international drug traffickers, including the Mexican drug cartels; disrupting illegal drug supply chains; expanding partnerships with state and local law enforcement; targeting “illicit finance,” including cryptocurrency-based sales; and other “coordinated enforcement efforts against transnational criminal organizations.”

Notably, the DEA Administrative Law Judge who was overseeing the rescheduling case announced his retirement last week, noting that moving forward, “all matters filed in this case will be forwarded to the DEA Administrator, for whatever action, if any, he deems appropriate.

President Trump said during last year’s election that he supported removing cannabis from Schedule I under the Controlled Substances Act, but since taking office, the second Trump administration has so far remained quiet on the issue.

Based in Portland, Oregon, Graham is Ganjapreneur’s Chief Editor. He has been writing about the legalization landscape since 2012 and has been contributing to Ganjapreneur since our official launch in…



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading
video31 minutes ago

Kentucky medical marijuana cultivator brings in half-grown plants to speed harvest

featured42 minutes ago

Federal Researchers Claim First-Ever Detection Of Cannabinoids In Human Breath After Use Of Marijuana Edibles

featured2 hours ago

BREEDING FOR BIG BUDS (1986)

featured5 hours ago

New DEA Admin Sidelines Cannabis Rescheduling Despite Earlier Promises

featured6 hours ago

New Rules in New Zealand Place Strict Guidelines on Medical Cannabis ‘Advertising’ 

video7 hours ago

South Beloit blood donors get marijuana products for their contribution

featured7 hours ago

Oklahoma Campaign to Legalize Adult-Use Cannabis Will Begin Collecting Signatures Next Month 

video8 hours ago

Bellbrook leaders pass ordinance banning marijuana sales

featured8 hours ago

PackworldUSA Highlights Versatile, Precision-Driven 3400 Series Heat Sealer for Cannabis Applications

featured9 hours ago

Federal Court Sides With Safe Drug Consumption Site, Saying Religious Protections Apply

featured10 hours ago

Trump’s New DEA Administrator Omits Cannabis Rescheduling From Top Priorities

featured11 hours ago

High Times, RAW and hhemp.co Forge New Era of Pre‑Rolls, Vapes & Hemp Products

featured13 hours ago

Bill To Ban Hemp Products With THC Is Filed In Texas House, As Governor Continues To Call For Regulations Instead

video13 hours ago

Illness linked to cannabis use sending more patients to the hospital, including NC woman

featured14 hours ago

Chicagoland Cookies Dispensary Opens in Illinois

featured15 hours ago

Is the Wait Over for Colombian Patients? Government May Allow Sale of Medical Cannabis Flowers

featured16 hours ago

NORML Remembers Richard Lee – NORML

featured17 hours ago

Bipartisan Coalition of 32 Attorneys General Call for Federal Cannabis Banking Reforms

featured18 hours ago

Trump Backs Pro-Marijuana-Legalization Lawmaker To Lead Republican National Committee

featured19 hours ago

Some Jokes To Bring A Monday Smile

featured20 hours ago

Grön Acquires New York Cannabis License

video20 hours ago

$2.5M prejudgment filed against men behind false cannabis license scheme: Tong

featured21 hours ago

Adult-Use Cannabis Bill Filed in Texas 

video22 hours ago

Pennsylvania AG joins coalition supporting cannabis banking reform

California Cannabis Updates1 year ago

Alert: Department of Cannabis Control updates data dashboards with full data for 2023 

Breaking News1 year ago

Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!

best list12 months ago

5 best CBD creams of 2024 by Leafly

Business10 months ago

EU initiative begins bid to open access to psychedelic therapies

Bay Smokes1 year ago

Free delta-9 gummies from Bay Smokes

cbd1 year ago

New Study Analyzes the Effects of THCV, CBD on Weight Loss

autoflower seeds10 months ago

5 best autoflower seed banks of 2024 by Leafly

California1 year ago

May 2024 Leafly HighLight: Pink Runtz strain

Breaking News1 year ago

Curaleaf Start Process Of Getting Their Claws Into The UK’s National Health System – With Former MP (Resigned Today 30/5/24) As The Front Man

Mississippi Cannabis News1 year ago

Mississippi city official pleads guilty to selling fake CBD products

cannabis brands10 months ago

Discover New York’s dankest cannabis brands [September 2024]

Mississippi Cannabis News1 year ago

Local medical cannabis dispensary reacts to MSDH pulling Rapid Analytics License – WLBT

Mississippi Cannabis News1 year ago

Horn Lake denies cannabis dispensary request to allow sale of drug paraphernalia and Sunday sales | News

Hemp1 year ago

Press Release: CANNRA Calls for Farm Bill to Clarify Existing State Authority to Regulate Hemp Products

Breaking News1 year ago

Nevada CCB to Accept Applications for Cannabis Establishments in White Pine County – “Only one cultivation and one production license will be awarded in White Pine County”

best list1 year ago

5 best THC drinks of 2024 by Leafly

Arkansas10 months ago

The Daily Hit: October 2, 2024

best list1 year ago

6 best CBD gummies of 2024 by Leafly

best list1 year ago

5 best delta-9 THC gummies of 2024 by Leafly

Breaking News1 year ago

Weekly Update: Monday, May 13, 2024 including, New Guide for Renewals & May Board meeting application deadline

Mississippi Cannabis News1 year ago

People In This State Googled ‘Medical Marijuana’ The Most, Study Shows

Breaking News1 year ago

PRESS RELEASE : Justice Department Submits Proposed Regulation to Reschedule Marijuana

Asia Pacific & Australia1 year ago

Thailand: Pro-cannabis advocates rally ahead of the government’s plan to recriminalize the plant

California Cannabis Updates1 year ago

Press Release: May 9, STIIIZY and Healing Urban Barrios hosted an Expungement Clinic & Second Chance Resource Fair

Trending